Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: J Surg Res. 2016 Dec 30;212:42–47. doi: 10.1016/j.jss.2016.12.032

Table 3.

Management and outcomes for all patients.

Management and outcomes n = 147
Endoscopy 140 (95%)
Angiography 14 (10%)
Surgery 13 (9%)
  Bowel resection 11 (7%)
Number of interventions 1.5 (1.3–1.7)
  Two or more interventions 39 (27%)
  Interval between interventions (h) 62 (50–78)
Patients who received a PRBC transfusion 64 (44%)
PRBC transfusions per patient 2.6 (1.6–4.2)
Hemoglobin (g/dL)
  Δ admission to nadir −1.8 (−2.1 to −1.5)
  Δ admission to discharge 0.1 (−0.3 to 0.5)
Creatinine (mg/dL)
  Δ admission to peak 0.2 (0.1 to 0.3)
  Δ admission to discharge −0.2 (−0.4 to −0.1)
Severe bleeding 61 (41%)
  Hematocrit decrease by 20% within 24 h 2 (1%)
  ≥2 units PRBC transfused 56 (38%)
  Readmission with LIB within 1 wk 9 (6%)
Hospital length of stay (d) 8.2 (7.1–9.6)
Intensive care unit length of stay (d) 1.4 (0.7–2.4)
Inpatient mortality 6 (4%)

PRBC = packed red blood cell.

Data are presented as n (%) or mean (95% confidence interval).